Provided by Tiger Trade Technology Pte. Ltd.

Exelixis

58.44
+0.11000.19%
Post-market: 58.26-0.1800-0.31%19:30 EDT
Volume:2.37M
Turnover:139.25M
Market Cap:14.48B
PE:18.38
High:59.27
Open:58.47
Low:57.88
Close:58.33
52wk High:61.14
52wk Low:33.76
Shares:247.78M
Float Shares:214.00M
Volume Ratio:1.08
T/O Rate:1.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.18
EPS(LYR):2.78
ROE:44.39%
ROA:23.97%
PB:7.85
PE(LYR):21.02

Loading ...

EXEL Industries Hit by Slump in Agricultural and Industrial Demand in Q3

TIPRANKS
·
Jul 24

Exelixis is Maintained at Equal-weight by Morgan Stanley

Dow Jones
·
Jul 24

Press Release: Exelixis to Release Second Quarter 2026 Financial Results on Wednesday, August 5, 2026

Dow Jones
·
Jul 23

Exelixis Schedules Quarterly Results Release and Investor Call

Reuters
·
Jul 23

Exelixis, Inc. : Barclays Raises Target Price to $49 from $45

THOMSON REUTERS
·
Jul 14

Exelixis price target raised to $49 from $45 at Barclays

TIPRANKS
·
Jul 14

Barclays Remains a Hold on Exelixis (EXEL)

TIPRANKS
·
Jul 14

Exelixis is Maintained at Equal-weight by Wells Fargo

Dow Jones
·
Jul 13

Exelixis price target raised to $56 from $54 at Truist

TIPRANKS
·
Jul 07

Exelixis is Maintained at Hold by Truist Securities

Dow Jones
·
Jul 07

RBC Capital Adjusts Exelixis Price Target to $46 From $43, Maintains Sector Perform Rating

MT Newswires Live
·
Jul 07

Is Exelixis (EXEL) Undervalued Or Already Priced In On Its Oncology Growth Story?

Simply Wall St.
·
Jul 05

Sector Update: Healthcare Stocks Gain Thursday Afternoon

MT Newswires Live
·
Jul 03

Exelixis Faces Balanced Risk-Reward Ahead of Key Catalysts, UBS Says

MT Newswires Live
·
Jul 03

UBS Adjusts Price Target on Exelixis to $52 From $43, Maintains Neutral Rating

MT Newswires Live
·
Jul 02

Exelixis Inc : UBS Raises Target Price to $52 from $43

THOMSON REUTERS
·
Jul 02

Exelixis is Maintained at Neutral by UBS

Dow Jones
·
Jul 02

Exelixis Price Target Maintained with a $56.00/share by HC Wainwright & Co.

Dow Jones
·
Jul 02

Apollo, Exelixis, Devon, Qualcomm, Oklo Trending With Analysts

TIPRANKS
·
Jun 27

Is Exelixis (EXEL) Fully Valued On Its STELLAR 303 Trial Update?

Simply Wall St.
·
Jun 27